Literature DB >> 25195792

Lung function in adult survivors of very low birth weight, with and without bronchopulmonary dysplasia.

Anne-Marie Gibson1,2, Charlotte Reddington2,3, Lucy McBride2,3, Catherine Callanan3, Colin Robertson1,2,4, Lex W Doyle1,2,3.   

Abstract

INTRODUCTION: The lung function outcome of cohorts of very low birth weight (VLBW; birth weight <1501 g) survivors born in the late 1970s or early 1980s into adulthood at an age when lung growth would be expected to have ceased is not well described. The aim of this study was to report lung function data in adulthood of VLBW survivors compared with normal birth weight controls (>2499 g), and in those who had bronchopulmonary dysplasia (BPD) compared with those without BPD.
MATERIALS AND METHODS: Spirometry and lung volumes were measured according to standard guidelines when subjects were in their mid-20s; there were 47 survivors of birth weight <1000 g, 40 of birth weight 1000-1500 g, and 20 controls of birth weight >2499 g. Results were converted to z-scores.
RESULTS: Both subgroups with birth weight <1501 g had significant reductions in airflow compared with controls, but not compared with each other. There were no significant differences between groups in variables reflecting air trapping. Within the VLBW cohort, those with BPD (n = 24) had reductions in airflow, including the z-score for the forced expired volume in 1 sec (FEV1 ), compared with those without BPD (n = 63). Within the VLBW cohort, there were positive relationships between FEV1 measurements earlier in childhood with those obtained at 25 years of age; these relationships were stronger in those who had BPD in the newborn period, and increased over time.
CONCLUSIONS: VLBW survivors continue to have airways obstruction in their mid-20s compared with controls, particularly those who had BPD in the newborn period.
© 2014 Wiley Periodicals, Inc.

Entities:  

Keywords:  adult; bronchopulmonary dysplasia; lung function; lung volumes; spirometry; very low birth weight

Mesh:

Year:  2014        PMID: 25195792     DOI: 10.1002/ppul.23093

Source DB:  PubMed          Journal:  Pediatr Pulmonol        ISSN: 1099-0496


  21 in total

1.  Respiratory morbidity, lung function and fitness assessment after bronchopulmonary dysplasia.

Authors:  M Praprotnik; I Stucin Gantar; M Lučovnik; T Avčin; U Krivec
Journal:  J Perinatol       Date:  2015-10-15       Impact factor: 2.521

Review 2.  Understanding the Short- and Long-Term Respiratory Outcomes of Prematurity and Bronchopulmonary Dysplasia.

Authors:  Jessica Y Islam; Roberta L Keller; Judy L Aschner; Tina V Hartert; Paul E Moore
Journal:  Am J Respir Crit Care Med       Date:  2015-07-15       Impact factor: 21.405

3.  Prediction Models for Bronchopulmonary Dysplasia in Preterm Infants: A Systematic Review.

Authors:  Hai-Bo Peng; Yuan-Li Zhan; You Chen; Zhen-Chao Jin; Fang Liu; Bo Wang; Zhang-Bin Yu
Journal:  Front Pediatr       Date:  2022-05-12       Impact factor: 3.569

Review 4.  Physiological aspects of cardiopulmonary dysanapsis on exercise in adults born preterm.

Authors:  Joseph W Duke; Adam J Lewandowski; Steven H Abman; Andrew T Lovering
Journal:  J Physiol       Date:  2022-01-12       Impact factor: 6.228

Review 5.  Trajectories of Lung Function in Infants and Children: Setting a Course for Lifelong Lung Health.

Authors:  Brian K Jordan; Cindy T McEvoy
Journal:  Pediatrics       Date:  2020-09-16       Impact factor: 7.124

Review 6.  Biomarkers, Early Diagnosis, and Clinical Predictors of Bronchopulmonary Dysplasia.

Authors:  Charitharth Vivek Lal; Namasivayam Ambalavanan
Journal:  Clin Perinatol       Date:  2015-10-01       Impact factor: 3.430

Review 7.  The Natural History of Bronchopulmonary Dysplasia: The Case for Primary Prevention.

Authors:  Cindy T McEvoy; Judy L Aschner
Journal:  Clin Perinatol       Date:  2015-10-01       Impact factor: 3.430

Review 8.  Can maternal DHA supplementation offer long-term protection against neonatal hyperoxic lung injury?

Authors:  Krithika Lingappan; Bhagavatula Moorthy
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2015-09-11       Impact factor: 5.464

9.  Lung function between 8 and 15 years of age in very preterm infants with fetal growth restriction.

Authors:  Michele Arigliani; Chiara Stocco; Elena Valentini; Carlo De Pieri; Luigi Castriotta; Maria Elena Ferrari; Cristina Canciani; Lorenza Driul; Maria Orsaria; Luigi Cattarossi; Paola Cogo
Journal:  Pediatr Res       Date:  2021-01-19       Impact factor: 3.756

10.  Lung function trajectories in children with post-prematurity respiratory disease: identifying risk factors for abnormal growth.

Authors:  Jonathan C Levin; Catherine A Sheils; Jonathan M Gaffin; Craig P Hersh; Lawrence M Rhein; Lystra P Hayden
Journal:  Respir Res       Date:  2021-05-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.